Specialties
Reports that name this provider
- Stem Cell Therapy Availability in South Korea
- Biotech company that operates clinics offering stem cell therapies. Commercialized CARTISTEM®, the world's first regulatory-approved umbilical cord blood-derived mesenchymal stem cell product. CELLTREE® cord blood bank ranks number one domestically with 15.8 billion won in sales and over 200,000 blood cords saved as of 2016.
- Stem Cell Therapy Quality in South Korea
- Manufactures Cartistem®; operates PIC/S-certified, MFDS-approved GMP Center with 58 large-scale cell culture incubators, 11 independent HVAC systems, and centralized liquid nitrogen supply for cryopreservation; submitted FDA IND amendment for Phase III US trials in February 2026